Back to Capital World Investors Capital World Investors

NAMSNAMS
7 quarters

Position history for Capital World InvestorsCapital World Investors's holdings in NewAmsterdam Pharma Company N.V.

Capital World Investors holds 12.2M shares of NAMS (NewAmsterdam Pharma Company N.V.), worth $414.5M as of 2026-Q2. The position was increased (+10.1% shares). NAMS represents 0.0% of Capital World Investors's portfolio.

Current Value

$414.5M

Current Shares

12.2M

Total Value Change

+$388.4M

Total Shares Change

+11.2M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
12.2M
+10.1%
$414.5M0.0%$33.89
34
2026-Q1
Increased
11.1M
+11.3%
$355.6M0.0%$30.41
35
2025-Q4
Increased
10M
+1.6%
$350.2M0.0%$34.74
31
2025-Q3
Increased
9.8M
+17.1%
$279.4M0.0%$27.52
36
2025-Q2
Increased
8.4M
+23.4%
$151.9M0.0%$18.57
37
2025-Q1
Increased
6.8M
+569.1%
$139.2M0.0%$21.76
49
2024-Q4
New
1M
-
$26.1M0.0%$25.60
40

Other major holders of NAMS: FMR LLC, RA CAPITAL MANAGEMENT, L.P.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used